India’s in-vitro fertilization (IVF) services market is on a strong upward trajectory, expected to touch USD 4.6 billion by 2032, driven by rising infertility rates, advancements in reproductive technology, and growing awareness and accessibility of fertility treatments across the country.
Rising demand for assisted reproduction
Infertility has become an increasing concern in India, affecting an estimated 10–14% of couples of reproductive age. Delayed marriages, changing lifestyles, stress, and environmental factors have all contributed to the rise in fertility challenges. The demand for assisted reproductive technologies (ART), especially IVF, has grown significantly in the past decade as more couples seek medical intervention to conceive.
Experts point out that both urbanization and awareness have played key roles in this trend. A decade ago, IVF was often considered an elite or last-resort treatment. Today, it is a mainstream medical service available not only in metro cities but also in Tier 2 and Tier 3 towns, with improved affordability and success rates.
Technological advancements driving growth
The use of advanced procedures such as ICSI (Intracytoplasmic Sperm Injection), blastocyst culture, embryo freezing (vitrification), and preimplantation genetic testing (PGT) has significantly improved IVF outcomes in India. Modern fertility centres are also investing in AI-assisted embryo selection, time-lapse incubators, and teleconsultation services, allowing for more accurate, efficient, and patient-friendly treatment journeys.
Fertility tourism adding to market expansion
India’s reputation as a cost-effective and high-quality fertility destination is drawing increasing numbers of international patients. IVF treatments in India are often 60–80% less expensive than in Western countries, making it a preferred destination for couples from the Middle East, Africa, and Southeast Asia. This surge in fertility tourism is expected to further boost market revenues over the next decade.
Market outlook and growth factors
Industry projections indicate that the IVF services market, which was valued at less than USD 1 billion a few years ago, is expected to grow at a compound annual growth rate (CAGR) of over 18% from 2023 to 2032, reaching approximately USD 4.6 billion by the end of the forecast period.
The expansion is being supported by:
- Increasing infertility awareness and diagnosis rates
- Favorable government regulations for ART clinics
- Rising disposable incomes and insurance coverage for select fertility procedures
- Growth of organized IVF clinic chains and hospital networks
Challenges ahead
Despite the positive outlook, the IVF industry faces challenges including high treatment costs, limited insurance support, and ethical concerns regarding donor programs and surrogacy. Regulatory compliance under India’s Assisted Reproductive Technology (Regulation) Act also remains crucial to maintaining patient safety and quality standards across clinics.
With a combination of medical innovation, affordability, and growing acceptance, India’s IVF services market is poised to become one of the largest globally in the next decade. The expected rise to USD 4.6 billion by 2032 underscores both the medical and socio-economic transformation of reproductive health services in the country — making India a central player in the global fertility landscape.